MA33242B1 - Composes pour le traitement de troubles metaboliques - Google Patents
Composes pour le traitement de troubles metaboliquesInfo
- Publication number
- MA33242B1 MA33242B1 MA34246A MA34246A MA33242B1 MA 33242 B1 MA33242 B1 MA 33242B1 MA 34246 A MA34246 A MA 34246A MA 34246 A MA34246 A MA 34246A MA 33242 B1 MA33242 B1 MA 33242B1
- Authority
- MA
- Morocco
- Prior art keywords
- metabolic disorders
- compounds
- treatment
- diabetes
- exhibit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne des composés thérapeutiques représentés par la formule (I), qui présentent une activité d'agonistes de GPR119 et sont utiles pour traiter des troubles métaboliques, y compris le diabète de type 2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0904287.0A GB0904287D0 (en) | 2009-03-12 | 2009-03-12 | Compounds for the treatment of metabolic disorders |
PCT/GB2010/050442 WO2010103335A1 (fr) | 2009-03-12 | 2010-03-12 | Composés pour le traitement de troubles métaboliques |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33242B1 true MA33242B1 (fr) | 2012-05-02 |
Family
ID=40600949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34246A MA33242B1 (fr) | 2009-03-12 | 2010-03-12 | Composes pour le traitement de troubles metaboliques |
Country Status (18)
Country | Link |
---|---|
US (1) | US20120040953A1 (fr) |
EP (1) | EP2406256A1 (fr) |
JP (1) | JP2012520284A (fr) |
KR (1) | KR20110130476A (fr) |
CN (1) | CN102395584A (fr) |
AU (1) | AU2010222673A1 (fr) |
BR (1) | BRPI1009781A2 (fr) |
CA (1) | CA2754794A1 (fr) |
CL (1) | CL2011002221A1 (fr) |
EA (1) | EA201190209A1 (fr) |
GB (1) | GB0904287D0 (fr) |
IL (1) | IL215051A0 (fr) |
MA (1) | MA33242B1 (fr) |
MX (1) | MX2011009491A (fr) |
PE (1) | PE20120356A1 (fr) |
SG (1) | SG174362A1 (fr) |
WO (1) | WO2010103335A1 (fr) |
ZA (1) | ZA201107446B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR077214A1 (es) | 2009-06-24 | 2011-08-10 | Neurocrine Biosciences Inc | Heterociclos nitrogenados y composiciones farmaceuticas que los contienen |
NZ596445A (en) | 2009-06-24 | 2013-04-26 | Boehringer Ingelheim Int | New compounds, pharmaceutical composition and methods relating thereto |
WO2011113947A1 (fr) | 2010-03-18 | 2011-09-22 | Boehringer Ingelheim International Gmbh | Combinaisons d'agonistes de gpr119 et d'inhibiteurs de dpp-iv, linagliptine, pour le traitement du diabète et d'états apparentés |
GB201006167D0 (en) * | 2010-04-14 | 2010-05-26 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
GB2488360A (en) * | 2011-02-25 | 2012-08-29 | Prosidion Ltd | Heterocyclic GPCR agonists |
GB201114389D0 (en) * | 2011-08-22 | 2011-10-05 | Prosidion Ltd | Novel compounds |
AR083904A1 (es) * | 2010-11-18 | 2013-04-10 | Prosidion Ltd | Derivados de 1,4-pirrolidinas disustituidos y 3-il-aminas y sus usos en el tratamiento de desordenes metabolicos |
JP6463631B2 (ja) | 2011-06-09 | 2019-02-06 | ライゼン・ファーマシューティカルズ・エスアー | Gpr−119のモジュレータとしての新規化合物 |
KR101881932B1 (ko) | 2011-12-07 | 2018-07-27 | 삼성전자주식회사 | 자기 소자 및 그 제조 방법 |
CN104780915A (zh) | 2012-07-11 | 2015-07-15 | 埃尔舍利克斯治疗公司 | 包含他汀、双胍和用于减小心脏代谢风险的其它药剂的组合物 |
US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
TW202229260A (zh) * | 2019-07-15 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 可用為幾丁質酶抑制劑的經取代的胺基三唑 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100042A (en) | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
GB9719496D0 (en) | 1997-09-13 | 1997-11-19 | Glaxo Group Ltd | G protien chimeras |
EP1123391A2 (fr) | 1998-09-01 | 2001-08-16 | BASF Aktiengesellschaft | Methodes permettant d'ameliorer la fonction des recepteurs heterologues couples a la proteine g |
US6221660B1 (en) | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
KR101154830B1 (ko) * | 2003-12-24 | 2012-06-18 | 프로시디온 리미티드 | Gpcr 수용체 효능제로서의 헤테로사이클릭 유도체 |
JP5065908B2 (ja) * | 2004-12-24 | 2012-11-07 | プロシディオン・リミテッド | Gタンパク質結合受容体作動薬 |
JP4980928B2 (ja) | 2004-12-24 | 2012-07-18 | プロシディオン・リミテッド | Gタンパク質共役受容体(gpr116)作動薬および肥満および糖尿病治療のためのその使用 |
GB0428514D0 (en) | 2004-12-31 | 2005-02-09 | Prosidion Ltd | Compounds |
US20090221644A1 (en) | 2005-06-30 | 2009-09-03 | Stuart Edward Bradley | Gpcr Agonists |
GB0513257D0 (en) * | 2005-06-30 | 2005-08-03 | Prosidion Ltd | Compounds |
WO2007003960A1 (fr) | 2005-06-30 | 2007-01-11 | Prosidion Limited | Agonistes du gpcr |
KR20080025190A (ko) | 2005-06-30 | 2008-03-19 | 프로시디온 리미티드 | G-단백질 결합된 수용체 효능제 |
WO2007003962A2 (fr) | 2005-06-30 | 2007-01-11 | Prosidion Limited | Agonistes de gpcr |
US20090203663A1 (en) | 2006-02-09 | 2009-08-13 | Astrazeneca Ab | Chemical compounds |
WO2007116229A1 (fr) | 2006-04-06 | 2007-10-18 | Prosidion Limited | Agonistes gpcr hétérocycliques |
GB0607196D0 (en) | 2006-04-11 | 2006-05-17 | Prosidion Ltd | G-protein coupled receptor agonists |
GB0610746D0 (en) | 2006-06-01 | 2006-07-12 | Prosidion Ltd | Method of treatment |
WO2007148185A2 (fr) | 2006-06-21 | 2007-12-27 | Pfizer Products Inc. | 3-amino-pyrrolidino-4-lactames substitués |
MX2009005935A (es) * | 2006-12-06 | 2009-06-30 | Smithkline Beecham Corp | Compuestos biciclicos y su uso como anti-diabeticos. |
ES2385759T3 (es) | 2006-12-22 | 2012-07-31 | Industrial Research Limited | Análogos azetidina de inhibidores de nucleosidasa y fosforilasa |
AR064735A1 (es) | 2007-01-04 | 2009-04-22 | Prosidion Ltd | Agonistas de gpcr y composicion farmaceutica en base al compuesto |
GB0700122D0 (en) | 2007-01-04 | 2007-02-14 | Prosidion Ltd | GPCR agonists |
CA2674360A1 (fr) | 2007-01-04 | 2008-07-10 | Prosidion Limited | Agonistes de gpcr piperidiniques |
PE20081849A1 (es) | 2007-01-04 | 2009-01-26 | Prosidion Ltd | Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr |
RS52065B (en) | 2007-01-04 | 2012-06-30 | Prosidion Ltd | PIPERIDINSKI GPCR AGONIST |
US20080186971A1 (en) | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
NZ582664A (en) | 2007-07-17 | 2012-03-30 | Bristol Myers Squibb Co | Pyridone gpr119 g protein-coupled receptor agonists |
JP2010539152A (ja) | 2007-09-10 | 2010-12-16 | プロシディオン・リミテッド | 代謝障害の治療のための化合物 |
JP4455675B2 (ja) | 2007-10-18 | 2010-04-21 | 日鉱金属株式会社 | 金属被覆ポリイミド複合体及び同複合体の製造方法並びに電子回路基板の製造方法 |
GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
CN101621337B (zh) | 2008-06-30 | 2013-08-07 | 华为技术有限公司 | 一种时延调节装置与方法 |
WO2010004343A1 (fr) | 2008-07-10 | 2010-01-14 | Prosidion Limited | Agonistes des récepteurs couplés aux protéines g (gpcr) piperidinyles |
GB0812648D0 (en) | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
US20110230507A1 (en) | 2008-07-10 | 2011-09-22 | Prosidion Limited | Piperidine GPCR Agonists |
GB0812641D0 (en) | 2008-07-10 | 2008-08-20 | Prosidion Ltd | Compounds |
-
2009
- 2009-03-12 GB GBGB0904287.0A patent/GB0904287D0/en not_active Ceased
-
2010
- 2010-03-12 EA EA201190209A patent/EA201190209A1/ru unknown
- 2010-03-12 BR BRPI1009781A patent/BRPI1009781A2/pt not_active Application Discontinuation
- 2010-03-12 SG SG2011065794A patent/SG174362A1/en unknown
- 2010-03-12 WO PCT/GB2010/050442 patent/WO2010103335A1/fr active Application Filing
- 2010-03-12 PE PE2011001633A patent/PE20120356A1/es not_active Application Discontinuation
- 2010-03-12 CN CN2010800164285A patent/CN102395584A/zh active Pending
- 2010-03-12 CA CA2754794A patent/CA2754794A1/fr not_active Abandoned
- 2010-03-12 KR KR1020117024020A patent/KR20110130476A/ko not_active Application Discontinuation
- 2010-03-12 MA MA34246A patent/MA33242B1/fr unknown
- 2010-03-12 AU AU2010222673A patent/AU2010222673A1/en not_active Abandoned
- 2010-03-12 MX MX2011009491A patent/MX2011009491A/es unknown
- 2010-03-12 US US13/255,536 patent/US20120040953A1/en not_active Abandoned
- 2010-03-12 EP EP10709926A patent/EP2406256A1/fr not_active Withdrawn
- 2010-03-12 JP JP2011553534A patent/JP2012520284A/ja active Pending
-
2011
- 2011-09-08 IL IL215051A patent/IL215051A0/en unknown
- 2011-09-08 CL CL2011002221A patent/CL2011002221A1/es unknown
- 2011-10-11 ZA ZA2011/07446A patent/ZA201107446B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI1009781A2 (pt) | 2016-03-08 |
CN102395584A (zh) | 2012-03-28 |
IL215051A0 (en) | 2011-11-30 |
EP2406256A1 (fr) | 2012-01-18 |
US20120040953A1 (en) | 2012-02-16 |
GB0904287D0 (en) | 2009-04-22 |
JP2012520284A (ja) | 2012-09-06 |
CA2754794A1 (fr) | 2010-09-16 |
PE20120356A1 (es) | 2012-04-16 |
ZA201107446B (en) | 2012-06-27 |
MX2011009491A (es) | 2011-10-11 |
EA201190209A1 (ru) | 2012-04-30 |
CL2011002221A1 (es) | 2012-07-06 |
SG174362A1 (en) | 2011-11-28 |
AU2010222673A1 (en) | 2011-11-03 |
KR20110130476A (ko) | 2011-12-05 |
WO2010103335A1 (fr) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33242B1 (fr) | Composes pour le traitement de troubles metaboliques | |
MA33190B1 (fr) | Composes pour le traitement de troubles metaboliques | |
MA33241B1 (fr) | Composes pour le traitement de troubles metaboliques | |
MX2009008159A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
TNSN08373A1 (en) | Azolopyrimidines as inhibitors of cannabinoid 1 activity | |
EA200700909A1 (ru) | Азаиндолкарбоксамиды | |
MA31158B1 (fr) | Composes tricycliques et leur utilisation comme modulateurs du recepteur de glucocorticoïdes | |
EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
MA34361B1 (fr) | Dérivés de tétrahydro-pyrido-pyrimidine | |
EA201000046A1 (ru) | Замещенные имидазогетероциклы | |
MA34235B1 (fr) | Composes chimiques | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
MA31084B1 (fr) | Derives de piperidine agonistes de gpcr | |
TW200612911A (en) | Compounds for the treatment of inflammatory disorders | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
MA32655B1 (fr) | Composés modulant sélectivement le récepteur cb2 | |
TW200736247A (en) | Compounds for the treatment of inflammatory disorders | |
TW200611695A (en) | Pyrrolopyridine derivatives | |
EA200701471A1 (ru) | Замещённые пиридинильные и пиримидинильные производные, используемые в качестве модуляторов метаболизма и лечение ассоциированных с ним расстройств | |
MX2010005861A (es) | Agonistas novedosos de los receptores de glucocorticoides. | |
MA33428B1 (fr) | Agonistes du gpr119 | |
TN2009000199A1 (en) | Heteromonocyclic compound and use thereof | |
EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
JO2686B1 (en) | Vehicles |